Johnson & Johnson Stock News

With the equities market seemingly soaring to one plateau after another, bringing up dividend aristocrat stocks seems overly cautious. These ideas represent companies that have increased their payout

ALERT: Today Could Be Your Best Shot At Early Retirement (Sponsored) If you want to retire before 65, pay attention.

Dividend Stock Watch List: Lanny's April 2024 Edition

Dividend investing is one of the prominent ways to build wealth. Whether you are building a retirement portfolio, want to leave a legacy, or are looking to use the dividend income to cover your expens

Johnson & Johnson and Abbott Laboratories have impressive track records of paying and growing their dividends. Both healthcare leaders have robust businesses and exciting growth opportunities.

The S&P 500 is up almost 10% this year, as a dovish Fed and tech sector enthusiasm brighten the outlook for all stocks, including some of the favorite long-term stocks that have been ignored amidst th

Johnson & Johnson (JNJ) collaborates with Nvidia to facilitate the creation of AI-based models and the deployment of applications, offering a route to scale within its digital ecosystem for surgery.

Johnson & Johnson (NYSE: JNJ) currently trades around $160 per share, 15% below its peak level of over $185 seen in April 2022, and it seems like it can see higher levels over time. JNJ stock was trad

Johnson & Johnson (JNJ) closed the most recent trading day at $156.76, moving -0.9% from the previous trading session.

Johnson & Johnson MedTech and Nvidia are developing new artificial intelligence applications for surgery.

Johnson & Johnson (JNJ) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.

J&J (JNJ) is looking for expansion of Carvykti's label for the treatment of adult patients with relapsed and lenalidomide-refractory multiple myeloma.

Investing in your golden years is very different from investing in your young age. You cannot take as much risk now, but you still want to see your money grow.

Johnson & Johnson is one of the top healthcare companies in the world, with a market cap of nearly $400 billion. The company, however, faces an uncertain future because of its unsettled talc lawsuits.

Tax season is often stressful. However, you can soften the tax blow by using this time to do some spring cleaning by selecting stocks that will benefit you during tax season.